Last 12 months
Inside the activity.
0 purchase rows · 65 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 12 |
| Jul 2026 | 0 | 6 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 21 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2021 Filed Sep 2, 2021 22:50 UTC |
Chaudhry Jagtar SinghDirector · President, CEO & Chairman · 10% owner
|
GrantCommon Stock | 193,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001713683-21-000144 · wf-form4_163062303143245.xml · nonDerivative · entry 1 Chaudhry Jagtar Singh · CIK 0001374436 · Director · President, CEO & Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,313 F1 · shares: Represents restricted stock units granted upon achievement of certain FY21 performance metrics pursuant to performance-based restricted stock units granted September 8, 2020 under Zscaler's Fiscal Year 2018 Incentive Plan. The restricted stock units will vest 100% on September 15, 2021. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:35 UTC |
Naughton EileenDirector
|
GrantCommon Stock | 2,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001713683-21-000151 · wf-form4_163070127542922.xml · nonDerivative · entry 1 Naughton Eileen · CIK 0001378072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,085 F1 · shares: The reported shares are represented by restricted stock units, which one-third vest on September 15, 2022 and the remaining RSUs will vest in eight equal quarterly installments thereafter. Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 00:35 UTC |
BLASING KARENDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0001713683-21-000141 · wf-form4_163037011062441.xml · derivative · entry 8 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,334 Underlying: Common Stock · 2,000 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The shares subject to the options are fully vested and immediately exercisable. Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 00:35 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 500 | $278.78 | $139,392.00 |
DisclosureSEC source: 0001713683-21-000141 · wf-form4_163037011062441.xml · nonDerivative · entry 6 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,763 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $278.51 to $279.08, inclusive. Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 00:35 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 700 | $278.07 | $194,646.97 |
DisclosureSEC source: 0001713683-21-000141 · wf-form4_163037011062441.xml · nonDerivative · entry 5 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,263 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $277.48 to $278.45, inclusive. Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 00:35 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 300 | $276.57 | $82,971.00 |
DisclosureSEC source: 0001713683-21-000141 · wf-form4_163037011062441.xml · nonDerivative · entry 4 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,963 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $276.40 to $276.70, inclusive. Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 00:35 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 400 | $275.77 | $110,309.00 |
DisclosureSEC source: 0001713683-21-000141 · wf-form4_163037011062441.xml · nonDerivative · entry 3 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,263 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.37 to $276.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) to this Form 4. Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 00:35 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $273.09 | $27,309.00 |
DisclosureSEC source: 0001713683-21-000141 · wf-form4_163037011062441.xml · nonDerivative · entry 2 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,663 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 00:35 UTC |
BLASING KARENDirector
|
Exercise / conversionCommon Stock | 2,000 | $5.82 | $11,640.00 |
DisclosureSEC source: 0001713683-21-000141 · wf-form4_163037011062441.xml · nonDerivative · entry 1 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2021 Filed Aug 21, 2021 00:33 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $5.93 | $0.00 |
DisclosureSEC source: 0001713683-21-000139 · wf-form4_162950601491187.xml · derivative · entry 12 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,333 Underlying: Common Stock · 7,000 shares Expires 2027-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: One-fourth of the shares subject to the option vest on November 1, 2018 and 1/48 of the shares vest monthly thereafter. Read SEC document |
| August 19, 2021 Filed Aug 21, 2021 00:33 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 200 | $245.41 | $49,082.00 |
DisclosureSEC source: 0001713683-21-000139 · wf-form4_162950601491187.xml · nonDerivative · entry 5 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,318 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $245.37 to $245.45, inclusive. Read SEC document |
| August 19, 2021 Filed Aug 21, 2021 00:33 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 4,244 | $244.54 | $1,037,815.03 |
DisclosureSEC source: 0001713683-21-000139 · wf-form4_162950601491187.xml · nonDerivative · entry 4 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,518 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $244.16 to $245.06, inclusive. Read SEC document |
| August 19, 2021 Filed Aug 21, 2021 00:33 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 2,200 | $243.66 | $536,044.96 |
DisclosureSEC source: 0001713683-21-000139 · wf-form4_162950601491187.xml · nonDerivative · entry 3 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,762 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $243.04 to $244.02, inclusive. Read SEC document |
| August 19, 2021 Filed Aug 21, 2021 00:33 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 356 | $242.20 | $86,222.99 |
DisclosureSEC source: 0001713683-21-000139 · wf-form4_162950601491187.xml · nonDerivative · entry 2 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,962 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.00 to $242.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) to this Form 4. Read SEC document |
| August 19, 2021 Filed Aug 21, 2021 00:33 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionCommon Stock | 7,000 | $5.93 | $41,475.00 |
DisclosureSEC source: 0001713683-21-000139 · wf-form4_162950601491187.xml · nonDerivative · entry 1 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,318 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 20:18 UTC |
BLASING KARENDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0001713683-21-000137 · wf-form4_162923149895295.xml · derivative · entry 7 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,334 Underlying: Common Stock · 2,000 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The shares subject to the options are fully vested and immediately exercisable. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 20:18 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 436 | $244.14 | $106,446.26 |
DisclosureSEC source: 0001713683-21-000137 · wf-form4_162923149895295.xml · nonDerivative · entry 5 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,763 F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $243.86 to $244.48, inclusive. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 20:18 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 964 | $243.44 | $234,673.75 |
DisclosureSEC source: 0001713683-21-000137 · wf-form4_162923149895295.xml · nonDerivative · entry 4 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,199 F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $242.85 to $243.84, inclusive. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 20:18 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 200 | $241.97 | $48,393.00 |
DisclosureSEC source: 0001713683-21-000137 · wf-form4_162923149895295.xml · nonDerivative · entry 3 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,163 F2 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $241.58 to $242.35, inclusive. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 20:18 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 400 | $239.97 | $95,989.00 |
DisclosureSEC source: 0001713683-21-000137 · wf-form4_162923149895295.xml · nonDerivative · entry 2 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,363 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $239.41 to $240.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) to this Form 4. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 20:18 UTC |
BLASING KARENDirector
|
Exercise / conversionCommon Stock | 2,000 | $5.82 | $11,640.00 |
DisclosureSEC source: 0001713683-21-000137 · wf-form4_162923149895295.xml · nonDerivative · entry 1 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2021 Filed Aug 6, 2021 23:22 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $5.93 | $0.00 |
DisclosureSEC source: 0001713683-21-000135 · wf-form4_162829214475027.xml · derivative · entry 12 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,333 Underlying: Common Stock · 7,000 shares Expires 2027-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: One-fourth of the shares subject to the option vest on November 1, 2018 and 1/48 of the shares vest monthly thereafter. Read SEC document |
| August 05, 2021 Filed Aug 6, 2021 23:22 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 100 | $249.50 | $24,950.00 |
DisclosureSEC source: 0001713683-21-000135 · wf-form4_162829214475027.xml · nonDerivative · entry 5 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,318 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. Read SEC document |
| August 05, 2021 Filed Aug 6, 2021 23:22 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 400 | $249.02 | $99,608.00 |
DisclosureSEC source: 0001713683-21-000135 · wf-form4_162829214475027.xml · nonDerivative · entry 4 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,418 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $248.44 to $249.33, inclusive. Read SEC document |
| August 05, 2021 Filed Aug 6, 2021 23:22 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,969 | $247.84 | $487,999.52 |
DisclosureSEC source: 0001713683-21-000135 · wf-form4_162829214475027.xml · nonDerivative · entry 3 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,818 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $247.42 to $248.25, inclusive. Read SEC document |
| August 05, 2021 Filed Aug 6, 2021 23:22 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 4,531 | $246.93 | $1,118,850.25 |
DisclosureSEC source: 0001713683-21-000135 · wf-form4_162829214475027.xml · nonDerivative · entry 2 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,787 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.41 to $247.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) to this Form 4. Read SEC document |
| August 05, 2021 Filed Aug 6, 2021 23:22 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionCommon Stock | 7,000 | $5.93 | $41,475.00 |
DisclosureSEC source: 0001713683-21-000135 · wf-form4_162829214475027.xml · nonDerivative · entry 1 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,318 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 20:56 UTC |
BLASING KARENDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0001713683-21-000133 · wf-form4_162811053922916.xml · derivative · entry 11 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,334 Underlying: Common Stock · 2,000 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The shares subject to the options are fully vested and immediately exercisable. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 20:56 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 307 | $241.54 | $74,153.61 |
DisclosureSEC source: 0001713683-21-000133 · wf-form4_162811053922916.xml · nonDerivative · entry 9 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,763 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $241.23 to $242.01, inclusive. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 20:56 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $239.66 | $23,966.00 |
DisclosureSEC source: 0001713683-21-000133 · wf-form4_162811053922916.xml · nonDerivative · entry 8 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,070 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 20:56 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 693 | $238.78 | $165,476.34 |
DisclosureSEC source: 0001713683-21-000133 · wf-form4_162811053922916.xml · nonDerivative · entry 7 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,170 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $238.44 to $239.23, inclusive. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 20:56 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 300 | $237.43 | $71,229.00 |
DisclosureSEC source: 0001713683-21-000133 · wf-form4_162811053922916.xml · nonDerivative · entry 6 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,863 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $237.28 to $237.59, inclusive. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 20:56 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $236.19 | $23,619.00 |
DisclosureSEC source: 0001713683-21-000133 · wf-form4_162811053922916.xml · nonDerivative · entry 5 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,163 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 20:56 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $234.27 | $23,427.00 |
DisclosureSEC source: 0001713683-21-000133 · wf-form4_162811053922916.xml · nonDerivative · entry 4 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,263 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 20:56 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 300 | $232.23 | $69,669.00 |
DisclosureSEC source: 0001713683-21-000133 · wf-form4_162811053922916.xml · nonDerivative · entry 3 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,363 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.16 to $232.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) to this Form 4. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 20:56 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $230.12 | $23,012.00 |
DisclosureSEC source: 0001713683-21-000133 · wf-form4_162811053922916.xml · nonDerivative · entry 2 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,663 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 20:56 UTC |
BLASING KARENDirector
|
Exercise / conversionCommon Stock | 2,000 | $5.82 | $11,640.00 |
DisclosureSEC source: 0001713683-21-000133 · wf-form4_162811053922916.xml · nonDerivative · entry 1 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 22, 2021 Filed Jul 26, 2021 20:20 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $5.93 | $0.00 |
DisclosureSEC source: 0001713683-21-000131 · wf-form4_162733078498618.xml · derivative · entry 14 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,333 Underlying: Common Stock · 7,000 shares Expires 2027-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: One-fourth of the shares subject to the option vest on November 1, 2018 and 1/48 of the shares vest monthly thereafter. Read SEC document |
| July 22, 2021 Filed Jul 26, 2021 20:20 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 100 | $237.28 | $23,728.00 |
DisclosureSEC source: 0001713683-21-000131 · wf-form4_162733078498618.xml · nonDerivative · entry 7 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,318 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. Read SEC document |
| July 22, 2021 Filed Jul 26, 2021 20:20 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,900 | $236.61 | $449,563.94 |
DisclosureSEC source: 0001713683-21-000131 · wf-form4_162733078498618.xml · nonDerivative · entry 6 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,418 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F6 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $236.19 to $237.15, inclusive. Read SEC document |
| July 22, 2021 Filed Jul 26, 2021 20:20 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 3,134 | $235.79 | $738,968.37 |
DisclosureSEC source: 0001713683-21-000131 · wf-form4_162733078498618.xml · nonDerivative · entry 5 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,318 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $235.19 to $236.18, inclusive. Read SEC document |
| July 22, 2021 Filed Jul 26, 2021 20:20 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,000 | $233.67 | $233,674.00 |
DisclosureSEC source: 0001713683-21-000131 · wf-form4_162733078498618.xml · nonDerivative · entry 4 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,452 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $233.31 to $234.28, inclusive. Read SEC document |
| July 22, 2021 Filed Jul 26, 2021 20:20 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 300 | $232.37 | $69,711.00 |
DisclosureSEC source: 0001713683-21-000131 · wf-form4_162733078498618.xml · nonDerivative · entry 3 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,452 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $232.15 to $232.79, inclusive. Read SEC document |
| July 22, 2021 Filed Jul 26, 2021 20:20 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 566 | $231.77 | $131,181.99 |
DisclosureSEC source: 0001713683-21-000131 · wf-form4_162733078498618.xml · nonDerivative · entry 2 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,752 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.03 to $232.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (6) to this Form 4. Read SEC document |
| July 22, 2021 Filed Jul 26, 2021 20:20 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionCommon Stock | 7,000 | $5.93 | $41,475.00 |
DisclosureSEC source: 0001713683-21-000131 · wf-form4_162733078498618.xml · nonDerivative · entry 1 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,318 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 19, 2021 Filed Jul 20, 2021 23:25 UTC |
BLASING KARENDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0001713683-21-000129 · wf-form4_162682349633657.xml · derivative · entry 8 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,334 Underlying: Common Stock · 2,000 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The shares subject to the options are fully vested and immediately exercisable. Read SEC document |
| July 19, 2021 Filed Jul 20, 2021 23:25 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 388 | $222.96 | $86,510.26 |
DisclosureSEC source: 0001713683-21-000129 · wf-form4_162682349633657.xml · nonDerivative · entry 6 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,763 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F6 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $222.81 to $223.06, inclusive. Read SEC document |
| July 19, 2021 Filed Jul 20, 2021 23:25 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 732 | $222.28 | $162,707.86 |
DisclosureSEC source: 0001713683-21-000129 · wf-form4_162682349633657.xml · nonDerivative · entry 5 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,151 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $221.59 to $222.50, inclusive. Read SEC document |
| July 19, 2021 Filed Jul 20, 2021 23:25 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 336 | $221.03 | $74,264.53 |
DisclosureSEC source: 0001713683-21-000129 · wf-form4_162682349633657.xml · nonDerivative · entry 4 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,883 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $220.57 to $221.55, inclusive. Read SEC document |
| July 19, 2021 Filed Jul 20, 2021 23:25 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 400 | $219.99 | $87,996.00 |
DisclosureSEC source: 0001713683-21-000129 · wf-form4_162682349633657.xml · nonDerivative · entry 3 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,219 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $219.54 to $220.18, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.